What does it take to turn decades of research into a world-first clinical trial that could transform lives?
Join us for an insightful presentation with Professor James St John, Head of Griffith's Clem Jones Centre for Neurobiology and Stem Cell Research, as he offers a behind-the-scenes look at a groundbreaking new therapy for spinal cord injury.
This Phase 1 human trial, the first of its kind in the world, is testing an innovative treatment that uses nasal cells to repair damaged spinal cords. It offers hope of restored independence and improved quality of life to thousands living with paralysis
What's in it for you?
Explore the science behind cell therapy and how a "nerve bridge" could change outcomes for spinal injury patients.
Understand the ethical, legal and safety considerations that underpin clinical trials.
Learn how philanthropy, government, and community partnerships fuel breakthroughs in medical research.
Hear why this research offers renewed hope for the future of treatment and rehabilitation.